Current risks of occupational blood-borne viral infection

Surgical Infections

Volumn 11, Issue 3, 2010, Pages 325-331

  Mohebati, Arash ^a   Davis, John Mihran ^b   Fry, Donald E ^c  

^a University of Medicine and Dentistry of New Jersey   (United States)

^b JERSEY SHORE UNIVERSITY MEDICAL CENTER   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATAZANAVIR PLUS RITONAVIR; EFAVIRENZ; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; EMTRICITABINE PLUS ZIDOVUDINE; FOSAMPRENAVIR PLUS RITONAVIR; HEPATITIS B VACCINE; HEPATITIS C VACCINE; INDIVAVIR PLUS RITONAVIR; LAMIVUDINE PLUS TENOFOVIR; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; RITONAVIR PLUS SAQUINAVIR; UNCLASSIFIED DRUG;

ADULT; BLOODBORNE BACTERIUM; DRUG SAFETY; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MEDICAL PRACTICE; NONHUMAN; OCCUPATIONAL HAZARD; OPERATING ROOM; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; UNITED STATES; VIRUS INFECTION; VIRUS TRANSMISSION; CROSS INFECTION; HEPACIVIRUS; ISOLATION AND PURIFICATION; OCCUPATIONAL DISEASES; RISK ASSESSMENT; TRANSMISSION; VIRUS DISEASES;

BLOOD-BORNE PATHOGENS; CROSS INFECTION; HEPACIVIRUS; HEPATITIS B VIRUS; HIV; HUMANS; OCCUPATIONAL DISEASES; RISK ASSESSMENT; UNITED STATES; VIRUS DISEASES;

EID: 77954894536     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/sur.2010.025     Document Type: Review

References (66)

1. Fahey JB, Koziol ED, Banks MS, Henderson KD. Frequency of nonparenteral occupational exposures to blood and body fluids before and after universal precautions training. Am J Med 1991;90:145-153
2. U.S. Centers for Disease Control and Prevention. Case-control study of HIV seroconversion in health-care workers after percutaneous exposure to HIV-infected blood\France, United Kingdom, and United States, January 1988-August 1994. MMWR Morbid Mortal Wkly Rep 1995;44:929-933.
3. Do NA, Ciesielski AC, Metler PR, et al. Occupationally acquired human immunodeficiency virus (HIV) infection: National case surveillance data during 20 years of the HIV epidemic in the United States. Infect Control Hosp Epidemiol 2003;24:86-96.
4. Lot F, Seguier JC, Fegueux S, et al. Probable Transmission of HIV from an orthopedic surgeon to a patient in France. Ann Intern Med 1999;130:1-6
5. U.S. Centers for Disease Control and Prevention. Update: Transmission of HIV infection during an invasive dental procedure-Florida. MMWR Morbid Mortal Wkly Rep 1991;40(RR-2):21-27, 33.
6. Thompson ND, Novak RT, Datta D, et al. Hepatitis C virus transmission in hemodialysis units: Importance of infection control practices and aseptic technique. Infect Control Hosp Epidemiol 2009;30:900-903.
7. Lessa F, Tak S, Devader SR, et al. Risk of infections associated with improperly reprocessed transrectal ultrasound-guided prostate biopsy equipment. Infect Control Hosp Epidemiol 2008;29:289-293.
8. Germain JM, Carbonne A, Thiers V, et al. Patient-to-patient transmission of hepatitis C virus through the use of multi-dose vials during general anesthesia. Infect Control Hosp Epidemiol 2005;26:789-792.
9. U.S. Centers for Disease Control and Prevention: Acute hepatitis C virus infections attributed to unsafe injection practices at an endoscopic clinic-Nevada 2007. MMWR Morb Mortal Wkly Rep. 2008;57:513-517.
10. Trumbell ML, Greiner DJ: Homologous serum jaundice: An occupational hazard to medical personnel. JAMA 1951;145: 965-967.
11. Kuh C, Ward WE. Occupational virus hepatitis: An apparent hazard for medical personnel. JAMA 1950;143:631-635
12. U.S. Centers for Disease Control and Prevention. Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers\a response to P.I. 100-607. The Health Omnibus Program Extension Act of 1988. MMWR Morbid Mortal Wkly Rep 1989;38(S-6):3-37.
13. Fry DE. The ABCs of hepatitis. Adv Surg 1999;33:413-437.
14. Gottlieb MS, Schroff R, Schanker HM, et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: Evidence of a new acquired cellular immunodeficiency. N Engl J Med 1981;305:1431.
15. Choo Q-L, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-362.
16. Recommendations for preventing transmission of human immunodeficiency virus and hepatitis B virus to patients during exposure-prone invasive procedures. MMWR Morb Mortal Wkly Rep 1991;40(RR-8):1-9.
17. Public Health and Welfare Act, 42 USC §300ee-2 (1994).
18. Occupational Safety and Health Administration. Occupational exposure to bloodborne pathogens: Final rule. Fed Reg 1991;56:64175.
19. American College of Surgeons. Statement on the surgeon and HIV infection. Available at www.facs.org=fellows- info=statements=st-13.html
20. American College of Surgeons. Statement on the surgeon and hepatitis. Available at www.facs.org=fellows-info= statements=st-22.html
21. Bartlett JA, Fath MJ, Demasi R, et al. An updated systematic overview of triple combination therapy in antiretroviral-nä?ve HIV-infected adults. AIDS 2006;20:2051-2064.
22. U.S. Centers for Disease Control and Prevention. HIV and AIDS\United States, 1981-2000. MMWR Morbid Mortal Wkly Rep 2001;50:430-434.
23. U.S. Centers for Disease Control and Prevention. HIV and AIDS in the United States: A picture of today's epidemic. Available at www.cdc.gov=hiv= topics=surveillance=united- states.htm
24. U.S. Centers for Disease Control and Prevention. Surveillance of occupationally acquired HIV=AIDS in healthcare personnel since 2006. Available at www.cdc.gov=ncidod= dhqp=bp-hcp-w-hiv.html
25. Robert LM, Chamberland ME, Cleveland JL, et al. Investigation of patients of health care workers infected with HIV. Centers for Disease Control and Prevention database. Ann Intern Med 1995;122:653-657.
26. Tokars JI, Chamberland ME, Schable CA, et al. A survey of occupational blood contact and human immunodeficiency virus infection among orthopedic surgeons. The American Academy of Orthopaedic Surgeons Serosurvey Study Committee. JAMA 1992;268:489-494.
27. Bell DM. Occupational risk of human immunodeficiency virus infection in health-care workers: An overview. Am J Med 1997;102(5B):9-15
28. U.S. Centers for Disease Control and Prevention. Public Health Service guidelines for the management of health-care worker exposures to HIV and recommendations for post-exposure prophylaxis. MMWR Morbid Mortal Wkly Rep 1998;47(No.RR-7):1-33.
29. Panlilio AL, Cardo DM, Grohskopf LA, et al. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. MMWR Morbid Mortal Wkly Rep 2005;54(RR09):1-17.
30. Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337:1733-1745.
31. Shapiro CN, Tokars JI, Chamberland ME; American Academy of Orthopaedic Surgeons Serosurvey Study Committee: Use of hepatitis-B vaccine and infection with hepatitis B and C among orthopaedic surgeons. J Bone Joint Surg 1996;78A:1791-1800.
32. Shapiro CN. Occupational risk of infection with hepatitis B and hepatitis C virus. Surg Clin North Am 1995;75:1047-1056.
33. Heptonstall J. Outbreaks of hepatitis B virus infection associated with infected surgical staff. CDR Weekly 1991;1:R81-R85.
34. Harpaz R, von Seidlein L, Averhoff FM, et al. Transmission of hepatitis B virus to multiple patients from a surgeon without evidence of inadequate infection control. N Engl J Med 1996;334:549-554.
35. Spijkerman IJB, van Doorn L-J, Jansssen MHW, et al. Transmission of hepatitis B virus from a surgeon to his patients during high-risk and low-risk surgical procedures during 4 years. Infect Control Hosp Epidemiol 2002;23:306-312.
36. Zajac BA, West DJ, McAleer WJ, Scolnick EM. Overview of clinical studies with hepatitis B vaccine made with recom-binant DNA. J Infect Dis 1986;13(Suppl):39-45.
37. Hadler SC, Francis DP, Maynard JE, et al. Long term im-munogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med 1986;315:209-214.
38. Halpern SD, Asch DA, Shaked A, et al. Inadequate hepatitis B vaccination and post-exposure evaluation among transplant surgeons: Prevalence, correlates, and implications. Ann Surg 2006;244:305-309.
39. U.S. Centers for Disease Control and Prevention. Updated U.S. public health service guidelines for the management of occupational exposure to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR Morbid Mortal Wkly Rep 2001;50:1-42.
40. Sheppard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005;5:558-567.
41. Howard RJ, Fry DE, Davis JM, et al. Hepatitis C virus infection in healthcare workers. J Am Coll Surg 1997;184:540-552
42. U.S. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus infection and HCV-related chronic disease. MMWR Morbid Mortal Wkly Rep 1998;47:1-39.
43. Krawczynski K, Alter MJ, Tankersley DL, et al. Effect of immune globulin on the prevention of experimental hepatitis C virus infection. J Infect Dis 1996;173:822-828.
44. Alter MJ. Occupational exposure to hepatitis C virus: A dilemma. Infect Control Hosp Epidemiol 1994;15:742-744
45. occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR Morbid Mortal Wkly Rep 2001;50(RR11):1-42.
46. Esteban JI, Gomez J, Martell M, et al. Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med 1996; 334:555-560.
47. Duckworth GJ, Heptonstall J, Aitken C. Transmission of hepatitis C virus from a surgeon to a patient: The incident control team. Commun Dis Public Health 1999;2:188-192.
48. Ross RS, Viazov S, Thromahlen M, et al. Risk of hepatitis C virus transmission from an infected gynecologist to patients: Results of a 7-year retrospective investigation. Arch Intern Med 2002;162:805-810.
49. Ross RS, Viazov S, Roggendorf M. Phylogenetic analysis indicates transmission of hepatitis C virus from an infected orthopaedic surgeon to a patient. J Med Virol 2002;66:461-467.
50. Allen M. Report on Las Vegas hepatitis C outbreak released. Las Vegas Sun, December 21, 2009. Available at www.lasvegassun.com=news=2009=dec=21= report-las-vegas-hepatitis-c-outbreak-released=
51. Bunch J. 5,700 may be at risk for hepatitis C in Colorado due to medical tech. Denver Post. July 3, 2009. Available at www.denverpost.com=news=ci- 12746614
52. Tokars IJ, Bell MD, Culver HD, et al. Percutaneous injuries during surgical procedures. JAMA 1992;267:2899-2904.
53. Panlilio LA, Foy RD, Edwards RJ, et al. Blood contacts during surgical procedures. JAMA 1991;265:1533-1537.
54. Tokars IJ, Culver HD, Mendelson HM, et al. Skin and mucous membrane contacts with blood during surgical procedures: Risk and prevention. Infect Control Hosp Epidemiol 2003;16:703-711.
55. Popejoy SL, Fry DE. Blood contact and exposure in the operating room. Surg Gynecol Obstet 1991;172:480-483.
56. Matta H, Thompson AM, Rainey JB. Does wearing two pairs of gloves protect operating theatre staff from skin contamination? Br Med J 1988;297:597-598.
57. Quebbeman EJ, Telford GJ, Wadsworth K, et al. Double gloving: Protecting surgeons from blood contamination in the operating room. Arch Surg 1992;127:213-217.
58. Tanner J, Parkinson H. Double gloving to reduce surgical cross-infection. Cochrane Database Syst Rev 2006;3:CD003087.
59. Florman S, Burgdorf M, Finigan K, et al. Efficacy of double gloving with an intrinsic indicator system. Surg Infect 2005; 6:385-395.
60. American College of Surgeons. Statement on blunt suture needles [ST-52]. Available at www.facs.org=fellows-info= statements=st-52.html
61. Berguer R, Heller PJ. Preventing sharps injuries in the operating room. J Am Coll Surg 2004;199:462-467.
62. Makary MA, Pronovost PJ, Weiss ES, et al. Sharpless surgery: A prospective study of the feasibility of performing operations using non-sharp techniques in an urban, university-based surgical practice. World J Surg 2006;30:1224-1229.
63. Narayanan Menon KV. Non-A to E hepatitis. Curr Opin Infect Dis 2002;15:529-534.
64. Alter HJ. Emerging, re-emerging and submerging infectious threats to the blood supply. Vox Sang 2004;87(Suppl 2):S56-S61.
65. Aguzzi A, Glatzel M. Prion infections, blood and transfusions. Nat Clin Pract Neurol 2006;2:321-329.
66. Ironside JW. Variant Creutzfeldt-Jakob disease: Risk of transmission by blood transfusion and blood therapies. Haemophilia 2006;12(Suppl 1):8-15.